The Marketing Communicator
SEE OTHER BRANDS

Global take on media and advertising news

Boeing's X-37B Spaceplane Takes Off for New Mission

(MENAFN) Boeing confirmed Friday that its X-37B Orbital Test Vehicle remains in good health after its recent launch, and is now proceeding with routine checks in orbit.

The spacecraft was launched at 11:50 p.m. Eastern Time Thursday, lifted into space aboard a SpaceX Falcon 9 rocket from NASA's Kennedy Space Center in Florida, marking the eighth mission for the X-37B.

According to Boeing, the mission includes an integrated service module designed to enhance payload capacity, enabling more advanced experimentation in space.

"Our role is to make sure the spaceplane is the most reliable testbed it can be," said Michelle Parker, vice president of Boeing Space Mission Systems. "Launch is the starting line for this mission, but the work that follows -- the quiet, methodical work on orbit, analysis and eventual return is where progress is earned."

Since its debut in 2010, the X-37B has completed seven previous missions and spent over 4,200 days in space, Boeing noted.

MENAFN23082025000045017169ID1109966127

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions